Use of acylated aminoacids as nutraceutical approach to prevent mild cognitive impairment

Patent number:

WO/2025/219147

No items found.

Role of nutraceuticals, specifically N-oleoyl-leucine (OLE), not only in the prevention but also in the reversal of cognitive decline. OLE is a well-tolerated amino acid naturally present in selected foods. The ultimate goal is to translate these findings into a marketable nutritional product.

Countries:
Spain
Regions:
Valencian Community
Centers:
CONSEJO SUPERIOR INVESTIGACION
Other entities:
Sectors:
Health
Subsectors:
TRL Level:
TRL 4 – technology validated in lab
BRL Level:
PDF Link:
Download here
Video Link:
Watch it here
Sustainable Development Goal:
SDG03: Good health and well-being
Applications

AAME has a natural origin, is concentrated in selected foods and its administration does not cause changes in the behavior, weight, or appearance of treated subjects. OLE’s value proposal is superior to other nutraceuticals-nootropics due to: - oral administration and easy intestine absortion - It crosses the blood-brain barrier (BBB) - It instructs the immune system (microglia) to encapsulate and eliminate toxic protein aggregates - Promotes neuroprotection against oxidative stress - Improves the cognitive abilities of administrated subjects In summary, unlike the active ingredients present in other commercial nutritional supplements, OLE has the ability to modify the course of cognitive decline and Alzheimer's disease.

Comments

Other related patents

Health

Miniaturized in vitro Device for Electrical Stimulation (MiDES)

Countries
Spain
Know more
Health
Chemicals
Food & Agro

FORMULATIONS COMPRISING LIPID SYSTEMS CARRYING BIOACTIVE COMPOUNDS, FOR USE AS IMMUNOTHERAPY POTENTIATORS OR ADJUVANTS FOR PATIENTS WITH CANCER OR IMMUNOLOGICAL DISORDERS

Countries
Spain
Know more
Health

A NEW BIOMARKER EXPRESSED IN PANCREATIC BETA CELLS USEFUL IN IMAGING OR TARGETING BETA CELLS

Countries
Belgium
Know more
Get back to patents directory